Haloperidol IV Dose for Acute Agitation and Delirium
For intravenous haloperidol in adults with severe agitation, psychosis, or delirium, start with 2.5-5 mg IV and repeat every 1-4 hours as needed, with a maximum of 20 mg per day. 1
Dosing Algorithm by Clinical Context
Acute Agitation/Severe Psychosis
- Initial dose: 2-5 mg IV 1
- Repeat dosing: Can be given as often as every hour, though 4-8 hour intervals are typically satisfactory 1
- Maximum: 20 mg per day 1
- Monitoring: ECG monitoring required for IV administration 2
Delirium Management
- Starting dose: 0.5-1 mg IV 2, 3
- PRN dosing: 0.5-1 mg IV every 1-2 hours as needed 2
- Scheduled dosing: If needed frequently, give every 8-12 hours 2
- Titration: Increase in 0.5-1 mg increments as required 3
- Maximum: 10 mg daily (5 mg daily in elderly) 3
- Severe distress: Consider higher starting dose of 1.5-3 mg if patient is severely distressed or poses immediate danger 3
Special Populations
Elderly/Frail/Debilitated Patients:
- Start with 0.25-0.5 mg and titrate gradually 2
- Maximum 5 mg daily 3
- Lower doses reduce risk of extrapyramidal symptoms and other adverse effects
Cancer/Palliative Care:
- Start with 0.5-1 mg IV/SC 2
- Can repeat every 1 hour PRN 2
- Continuous infusion option: 2.5-10 mg over 24 hours 3
Critical Considerations
When to Add Benzodiazepines
If agitation persists despite haloperidol, add lorazepam or midazolam rather than escalating haloperidol alone 4. The combination of haloperidol 2 mg + lorazepam 3 mg IV showed superior agitation control compared to haloperidol alone in advanced cancer patients 5.
Monitoring Requirements
- ECG monitoring mandatory for IV administration due to QTc prolongation risk 2, 1
- Monitor for extrapyramidal symptoms, particularly dystonia 2, 1
- Watch for orthostatic hypotension and cardiac dysrhythmias 2
Contraindications
- Parkinson's disease or dementia with Lewy bodies (high risk of severe extrapyramidal symptoms) 2
- Pre-existing QTc prolongation
- Severe cardiac disease
Evidence Quality and Limitations
The 2018 ESMO guidelines 2 and 2020 NICE guidelines 3 provide the most authoritative dosing recommendations, though they acknowledge limited high-quality evidence for specific doses. Recent large RCTs 6, 7 found haloperidol does not reduce delirium duration or improve mortality in ICU patients, but it may reduce rescue medication requirements 8. The FDA label 1 remains the definitive source for approved dosing ranges.
Common Pitfalls
- Avoid excessive dosing: Doses >10 mg daily in elderly patients increase adverse effects without improving efficacy 3
- Don't use as monotherapy for alcohol/benzodiazepine withdrawal: Benzodiazepines are first-line 2
- Recognize paradoxical agitation: Can occur with haloperidol; consider switching to atypical antipsychotic 2
- Don't forget anticholinergic prophylaxis: Consider diphenhydramine 25-50 mg to prevent acute dystonia, especially in younger patients 4
Route Conversion
When switching from IV to oral: use the total parenteral dose from the preceding 24 hours as the initial oral dose estimate, given within 12-24 hours of the last parenteral dose 1. Monitor closely for the first several days and adjust accordingly.